Shortlist by what you need
Start here if you know why you are leaving Proscia.
Want the closest match?
PathAIMost similar to Proscia in what it does, its category and its price.
Visit (opens PathAI in a new tab)Want the best rated?
ArteraRated 4.4 out of 5 in our review, against 4.3 for Proscia.
Visit (opens Artera in a new tab)
At a glance
Green means better than Proscia, red means worse. Prices are starting prices per month.
| Tool | Our rating | Starts at | Free plan | Best for | Compare |
|---|---|---|---|---|---|
 ProsciaBaseline | 4.3 | Not listed | No | FDA-cleared digital pathology platform for primary diagnosis and biomarker research. | |
| PathAI | 4.3Same | Not listed | No | First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp | vs Proscia |
 Paige | 4.1−0.2 | Not listed | No | Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025 | vs Proscia |
 Bioptimus | 4.2−0.1 | Not listed | No | Foundation models for biology spanning molecular, cellular and tissue scales | vs Proscia |
| Artera | 4.4+0.1 | Not listed | No | FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions. | vs Proscia |
 Qureight | 4.1−0.2 | Not listed | No | Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab. | vs Proscia |
 AZmed | 4.4+0.1 | Not listed | No | FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays. | vs Proscia |
 Rayscape | 3.7−0.6 | Not listed | No | FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm. | vs Proscia |
 CARPL.ai | 4.2−0.1 | Not listed | No | A vendor-neutral marketplace where radiologists test and deploy third-party AI algorithms against their own imaging data behind their own firewall. | vs Proscia |
The alternatives in detail
In order of how closely each one matches Proscia.
PathAI
4.3Not listed
vs ProsciaSame
First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp.
- AISight Dx analyzes digital pathology slide images to assist diagnosis
- FDA 510(k) clearance for primary diagnosis in clinical settings, June 2025
- Predetermined Change Control Plan allows faster future software updates
Genuine FDA clearance for primary diagnosis, not just an assistive tool
Enterprise quote-based pricing requires a sales conversation, no published rates
Paige
4.1Not listed
vs Proscia−0.2
Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025.
- Paige Alba AI co-pilot for digital pathology tissue-slide analysis
- Cancer diagnosis, tissue subtyping, and molecular biomarker discovery support
- Founded in 2017 by researchers from Memorial Sloan Kettering Cancer Center
Research pedigree from Memorial Sloan Kettering lends real clinical credibility
Enterprise-only pricing requires a sales conversation before evaluation
Bioptimus
4.2Not listed
vs Proscia−0.1
Foundation models for biology spanning molecular, cellular and tissue scales.
- Foundation models trained across molecular, cellular and tissue scales
- Digital pathology models for research and trial workflows
- Transfer learning that reuses existing imaging and omics archives
Cross-scale model design rather than one narrow task classifier
Requires in-house validation on local cohorts before clinical reliance
Artera
4.4Not listed
vs Proscia+0.1
FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions.
- Multimodal AI trained on digitized biopsy images paired with clinical data
- FDA De Novo authorization for the ArteraAI Prostate Test
- FDA clearance for ArteraAI Breast digital pathology risk stratification
Regulatory clearance (FDA De Novo, NCCN guideline inclusion) beyond most AI health startups
Not a self-serve software product; access runs through labs, clinicians, and insurance billing
Qureight
4.1Not listed
vs Proscia−0.2
Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab.
- Deep-learning lung imaging biomarkers Lung8, Air8 and Fibr8
- Glass8 and Vascul8 for vascular and parenchymal measures
- Central reads and endpoint discovery for trials
Consistent measurement reduces the variability that costs trial power
No published pricing; sold to trial sponsors
AZmed
4.4Not listed
vs Proscia+0.1
FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays.
- FDA-cleared fracture, joint effusion, and dislocation detection (AZtrauma)
- FDA-cleared chest X-ray triage for nodules, pneumothorax, and pleural effusion (AZchest)
- Pediatric and adult population coverage
Multiple FDA clearances rather than a single narrow approval
No public pricing; only reachable through a sales demo
Rayscape
3.7Not listed
vs Proscia−0.6
FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm.
- 148+ pathology detection on chest X-rays
- Pulmonary nodule detection, measurement, and tracking on lung CT
- Multiple FDA clearances and extensive clinical validation
Genuine regulatory clearance (FDA) rather than just a marketing claim
Pricing isn't public - requires direct institutional engagement
CARPL.ai
4.2Not listed
vs Proscia−0.1
A vendor-neutral marketplace where radiologists test and deploy third-party AI algorithms against their own imaging data behind their own firewall.
- Marketplace access to 275+ third-party radiology AI applications
- Universal AI viewer that standardizes output across vendors
- On-premises testing of algorithms against a hospital's own data before deployment
Vendor-neutral marketplace avoids locking a hospital into one AI vendor's roadmap
No published pricing, enterprise sales process required to get a quote
FAQ
Questions people ask
Is Proscia free?
Proscia does not list a free plan. Check its pricing page for current plans.
How did you pick these alternatives?
We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.